 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
ORIGINAL ARTICLE
Minerva Cardioangiologica 2018 February;66(1):1-5
DOI: 10.23736/S0026-4725.17.04500-5
Copyright © 2017 EDIZIONI MINERVA MEDICA
language: English
Budget impact analysis of rivaroxaban vs. warfarin anticoagulation strategy for direct current cardioversion in non-valvular atrial fibrillation patients: the MonaldiVert Economic Study
Vincenzo RUSSO 1, Anna RAGO 1, Andrea A. PAPA 1 ✉, Valter BIANCHI 2, Vincenzo TAVOLETTA 2, Stefano DE VIVO 2, Ciro CAVALLARO 2, Gerardo NIGRO 1, Antonio D’ONOFRIO 2
| ACCESS OPTIONS | |
|
You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of € 45,00. Downloading and printing for personal use allowed. Access as an individual subscriber Access through your institution |
Subscribe to Minerva Cardiology and Angiology |
Institutional access